We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6479:TSEMinebeaMitsumi Inc. Analysis

Data as of 2026-03-14 - not real-time

¥2,776.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Minebea Mitsumi is trading well beneath its discounted cash‑flow estimate, offering a sizable margin of safety. Technical signals show the stock in oversold territory with a low RSI and a bearish MACD divergence, yet price is perched just above a clear support level and volume is on the rise, hinting at a potential short‑term bounce. The company delivers strong double‑digit revenue growth and a forward PE that is markedly lower than the industry average, reinforcing its undervalued stance. With a modest dividend yield, a payout ratio comfortably below 40%, and a low beta, the equity presents a defensive tilt despite elevated 30‑day volatility.
The balance sheet features ample cash relative to debt, and the sector’s demand for precision electronic components supports a durable growth narrative. Investor sentiment leans toward greed, aligning with the upside potential indicated by the fair‑value model. Overall, the fundamentals, valuation gap, and improving technical backdrop suggest a favorable risk‑adjusted opportunity across horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • oversold RSI indicating potential price rebound
  • price holding just above identified support
  • increasing trading volume supporting momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • double‑digit revenue growth driving earnings expansion
  • valuation gap with DCF fair value suggesting upside
  • low PE relative to industry enhancing value appeal

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • sustained demand for precision electronic components
  • strong cash position offsetting leverage concerns
  • stable dividend and low beta offering defensive characteristics

Key Metrics & Analysis

Financial Health

Revenue Growth22.80%
P/E Ratio17.7
Debt/Equity59.22
P/B Ratio1.3
Op. Cash Flow¥84.3B
Free Cash Flow¥-37524373504
Industry P/E33.7

Technical Analysis

TrendNeutral
RSI31.6
Support¥2,651.50
Resistance¥3,523.00
MA 20¥3,147.48
MA 50¥3,200.93
MA 200¥2,758.71
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value¥4,329.58
Target Price¥3,578.00
Upside/Downside28.87%
GradeUndervalued
TypeBlend
Dividend Yield1.80%

Risk Assessment

Beta0.75
Volatility47.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.